Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer

Suguru Tokiwa,1 Hiroaki Shimmura,1 Shuhei Nomura,2–4 Ryota Watanabe,1 Minoru Kurita,1 Naoto Yoshida,1 Kaori Yamashita,1 Yoshitaka Nishikawa,5 Alexander Kouzmenko,6 Shigeaki Kato4 1Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan; 2Department of Epidemiology an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tokiwa S, Shimmura H, Nomura S, Watanabe R, Kurita M, Yoshida N, Yamashita K, Nishikawa Y, Kouzmenko A, Kato S
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2017-12-01
Col·lecció:	Research and Reports in Urology
Matèries:	GnRH antagonists Prostate cancer Degarelix Discontinuation Diabetes Antithrombotic treatment
Accés en línia:	https://www.dovepress.com/degarelix-treatment-is-compatible-with-diabetes-and-antithrombotic-the-peer-reviewed-article-RRU
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!